TherapeuticsMD, Inc. (TXMD) › Capital ExpendituresTherapeuticsMD, Inc. (TXMD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $28.8K2012: $66.4K2013: $40.8K2014: $31.0K2015: $165.3K2016: $396.2K2017: $61.8K2018: $217.0K2019: $2.45M2020: $207.0K2021: $34.0K$34.0K2011Capital Expenditures (USD)2021Fiscal YearCapital ExpendituresChange YoY2021$34.0K-83.6%2020$207.0K-91.6%2019$2.45M+1028.8%2018$217.0K+251.1%2017$61.8K-84.4%2016$396.2K+139.7%2015$165.3K+433.7%2014$31.0K-24.1%2013$40.8K-38.6%2012$66.4K+130.8%2011$28.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share